期刊文献+

老年高血压人群高敏C反应蛋白增高与新发心脑血管事件的关系 被引量:21

Relation between hs-CRP and first cardio-cerebral vascular events in elderly hypertensive patients
在线阅读 下载PDF
导出
摘要 目的探讨血清高敏C反应蛋白(high sensitivity C-reactive protein,hs-CRP)增高对老年高血压人群新发心脑血管事件的影响。方法选择我院健康体检、年龄60~80岁的老年高血压人群5021例,行血清hs-CRP检测,从hs-CRP 0~5mg/L 3321例中随机选500例为正常组;从hs-CRP>5mg/L且≤10mg/L的1700例中随机选500例为增高组。随访3年,随访期每6个月收集1次新发心脑血管事件情况。比较新发心脑血管事件发生率。结果增高组新发心脑血管事件、脑梗死、非致死性急性心肌梗死发生率明显高于正常组,差异有统计学意义(14.4%vs 8.0%,7.0%vs 3.8%,5.2%vs 2.6%,P<0.05,P<0.01)。增高组累计无事件生存率明显低于正常组,随时间延长而逐渐明显,至随访3年结束时,生存率比较差异有统计学意义(P<0.05)。Cox比例风险回归分析显示,hs-CRP是心脑血管事件发生的独立危险因素,风险比3.67。结论 hs-CRP水平增高的老年高血压人群发生临床心脑血管事件的危险增加,尤其是脑梗死和心肌梗死的危险。 Objective To study the effect of hs-CRP on first cardio-cerebral vascular events in eld erly hypertensive patients. Methods Five thousand and twenty-one 60--80 years old hypertensive patients who underwent hs-CRP test were included in this study. Five hundred out of the 3321 patients with their hs-CRP being 0--5 mg/L served as a normal hs-CRP group and 500 out of the 1700 patients with their hs-CRP 〉5 mg/L but ≤10 mg/L served as a high hs-CRP group. The patients were followed up for 3 years during which the incidence of first cardio-cerebral vascular events was recorded every 6 months and compared. Results The incidence of first cardio-eerebral vascular events, cerebral infarction and non-fetal myocardial infarction was significantly higher in high hs-CRP group than in normal hs-CRP group(14. 4% vs 8. 0%,7. 0% vs 3. 8%,5.2% vs 2.6%,P〈0.05,P〈0.01). The accumulated events-free survival rate was lower in high hs-CRP group than in normal hs-CRP group at the end of 3-year follow-up(P〈0.05). Cox regression analysis showed that hs-CRP was the independent risk factor for cardio-cerebral vascular events. Conclusion The risk to occur cardio-cerebral vascular events,especially cerebral and myocardial infarction,increases in elderly hypertensive patients with a high hs-CRP level.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2013年第1期26-28,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 高血压 C反应蛋白质 心肌梗死 糖尿病 内皮 血管 脑梗死 hypertension C-reactive protein myocardia infarction diabetes mellitus endothelium, vascular ~ brain infarction
  • 相关文献

参考文献11

  • 1Morrow DA, de Lemos JA, Sabatine MS, et al. Clinical rele- vance of C reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to Zocor Trial. Circulation, 2006,114 : 281-288.
  • 2Zipes DP, Camn AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a re- port of the American College of Cardiology/American Heart Association task force and the European Society of Cardiology Committee for Practice Guidelines(writing committee to de- velop in collaboration with the European Heart Rhythm As- sociation and the Heart Rhythm Society). Europace, 2006,8: 746-837.
  • 3中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 4王艳秀,吴寿岭,朱婕,王剑利,金成,赵海燕,侯国盛,李冬青,李金锋,邸艳荣.高敏C反应蛋白对新发缺血性脑卒中风险的预测价值[J].中华高血压杂志,2010,18(3):244-248. 被引量:52
  • 5王剑利,王丽晔,高竞生,郑晓明,杨晓利,邢佳侬,吴寿岭,许绍中.高敏C反应蛋白对无高血压病史糖尿病人群新发心脑血管事件的影响[J].中国糖尿病杂志,2012,20(6):431-434. 被引量:6
  • 6Elkind MS, Lnna JM, Moon YP, et al. High sensitivity C-re- active protein predicts mortality but not stroke: the Northern Manhattan study. Neurology, 2009,73 : 1300-1307.
  • 7Arima H, Anderson C, Omae T. For the PROGRESS Collabo- rative Group. Perindopri[ based blood pressure lowering re duces major vascular events in Asian and Western participants with cerebrovascular disease:The PROGRESS trial. J Hyper tens,2010,28:395 400.
  • 8Zanchetti A,Mancia G,Blaek HR,et al. Facts and fallacies of blood pressure control in recent trials implications in the management of patients with hypertension. J Hypertension, 2009,27 : 673-679.
  • 9Blood pressure lowering treatment trialists' collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analy sis of randomised trials. BMJ, 2008,336 : 1121-1123.
  • 10Bowman TS, Sesso HD, Gaziano JM. Effect of age on blood pressure parameters and risk of cardiovascular death in men. AMJ Hypertens, 2006,19 : 47-52.

二级参考文献34

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33091
  • 2中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 3Chamorro A. Role of inflamination in stroke and atberotbrombosis[J].Cerebrovasc Dis. 2004,17(supp13) : 1-5.
  • 4Ridker PM, Cushman M, Stampfer M J, etal. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men[J]. N Engl J Med,1997,336(14) : 973-979.
  • 5Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of Creactive protein and risk of ischemic stroke and transient ischernic attack: the Framingham study[J].Stroke, 2001,32 ( 11 ) : 2575- 2579.
  • 6Kayaba K, Ishikawa S, Gotoh T, et al. Five-year intra-individual variability in C-reactive protein levels in a Japanese populationbased study-the Jichi medical school cohort study at Yamato, 1993- 1998[J]. Jpn Circ J ,2000,64(4):303- 308.
  • 7Wakugawa Y, Kiyohara Y, Tanizaki Y, et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study[ J ]. Stroke, 2006, 37 (1) : 27-32.
  • 8Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein : clinical importance[J]. Curr Probl Cardiol, 2004,29 (8): 439- 493.
  • 9De Maat MP, Trion A. C-reactive protein as a risk factor versus risk marker[J]. Curr-Opin Lipidol, 2004,15 ( 6 ) : 651-657.
  • 10Tohgi H, Konno S, Takahashi S, etal. Activated eoagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with insreaded Creactined protein levels[J].Thromb Res, 2000,100(5) :373-379.

共引文献903

同被引文献184

引证文献21

二级引证文献176

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部